Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)

Market Cap	4.21T
Revenue (ttm)	1.67T
Net Income (ttm)	227.31B
Shares Out	93.59M
EPS (ttm)	2,429.72
PE Ratio	18.52
Forward PE	16.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	886,375
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	39,000 - 48,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About DBD

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; antifungal and antiviral drugs; hemodialysis solutions; hepatobiliary; analgesic and antipyretic drugs; anti-inflammatory analgesic drugs; drugs for muscle, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs for brain circulation improvement; vitamins and minerals; endocrine hormones; ...

• Industry: Pharmaceutical Preparations
• CEO: Huong Thi Pham
• Employees: 1,303
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBD

Financial Performance

In 2023, DBD's revenue was 1.65 trillion, an increase of 6.24% compared to the previous year's 1.55 trillion. Earnings were 231.39 billion, an increase of 10.47%.